IL-20受体信号限制银屑病炎症中的IL-17产生
该研究在咪喹莫特诱导的小鼠银屑病模型中,揭示IL-20受体信号(包括对IL-19的响应)可限制银屑病炎症的某些方面。IL-20受体信号抑制真皮CCL2趋化因子产生,减少CCL2驱动的炎症细胞(包括产IL-17A的γδT细胞)真皮浸润,构成负反馈环路。IL-17A在角质形成细胞中强烈诱导IL-19。
要点
- IL-20受体信号通过抑制CCL2减少产IL-17A的γδT细胞真皮浸润。
- IL-17A诱导角质形成细胞产生IL-19,形成负反馈以减轻炎症损伤。
- IL-17在银屑病中既驱动真皮和表皮标志性改变,也启动限制损伤的通路。
核心结论
- IL-20受体信号(包括对IL-19的响应)限制咪喹莫特诱导的银屑病炎症的某些方面。
- 该信号构成负反馈环路:IL-17A诱导角质形成细胞产生IL-19,IL-19经IL-20受体抑制CCL2及炎症细胞浸润。
- IL-17细胞因子在银屑病炎症中作用动态,既驱动真皮和表皮标志性改变,也启动减轻炎症损伤的途径。
研究设计与样本
- 研究采用咪喹莫特诱导的小鼠银屑病模型。
主要发现
- IL-20受体信号抑制真皮CCL2趋化因子产生。
- IL-20受体信号减少CCL2驱动的炎症细胞真皮浸润,包括产IL-17A的γδT细胞。
- IL-17A在角质形成细胞中强烈诱导IL-19。
临床怎么用
- 提示IL-20受体信号是银屑病炎症中的内源性负反馈调节通路,可能影响IL-17靶向治疗的炎症动态。
局限性
- 研究基于小鼠咪喹莫特诱导模型,结论向人类银屑病的转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IL-17 cytokines, in particular IL-17A, are critical effectors in psoriasis. Antibodies that block IL-17A are highly efficacious in treating psoriasis. Likewise, disruption of IL-17 cytokines signaling, such as via the loss of the adaptor CIKS/Act1, ameliorates inflammation in mouse models of psoriasis. IL-17A promotes a cascade of effects, including the robust production of IL-19 in both humans and mice. IL-19, along with IL-20 and IL-24, signal via IL-20 receptors and comprise a subgroup within the IL-10 cytokine family. The role of these three cytokines in psoriasis is unresolved. They have been linked to inflammatory processes, including psoriatic pathology, but these cytokines have also been reported to suppress inflammation in other contexts. In this study, we demonstrate that signaling via IL-20 receptors, including in response to IL-19, delimited aspects of imiquimod-induced psoriatic inflammation. IL-20 receptor signaling suppressed the dermal production of the CCL2 chemokine and thereby reduced CCL-2-driven infiltration of inflammatory cells into the dermis, including IL-17A-producing γδT cells. This constitutes a negative feedback, since IL-17A strongly induces IL-19 in keratinocytes. The effects of IL-17 cytokines in this inflammatory setting are dynamic; they are central to the development of both dermal and epidermal hallmarks of psoriasis but also initiate a path to mitigate inflammatory damage.
引用
- Ha HL, Wang H, Claudio E, et al. IL-20-Receptor Signaling Delimits IL-17 Production in Psoriatic Inflammation. J Invest Dermatol. 2019. PMID: 31252033. doi:10.1016/j.jid.2019.06.127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。